Sublingual immunotherapy
Sublingual immunotherapy
复制标题
DOI：
10.1056/nejmct0708337
复制
发表时间：
2008-05-22
影响因子：
158.5
通讯作者：
Frew, Anthony J.
中科院分区：
文献类型：
--
作者：
Frew, Anthony J.
一位28岁的男性患有过敏性鼻炎，主要是由于草花粉，以前对抗组胺药和鼻喷雾剂没有反应。建议进行舌下免疫治疗试验。舌下免疫治疗比注射免疫治疗更方便。然而，只有一种专门针对草花粉过敏的药物在一些欧洲国家被批准用于临床。美国食品和药物管理局尚未批准任何舌下免疫治疗剂。
A 28-year-old man presents with allergic rhinitis, primarily due to grass pollen, that has not previously responded to antihistamines and nasal sprays. A trial of sublingual immunotherapy is recommended. Sublingual immunotherapy is more convenient than injection immunotherapy. However, only one agent, which is specific for grass-pollen allergies, has been approved for clinical use in some European countries. The Food and Drug Administration has not approved any agent for sublingual immunotherapy.